Derikx LAAP, Dolby HW, Plevris N, Lucaciu L, et al. Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naive SB5 Observational Cohorts. J Crohns Colitis 2021;15:2011-2021.
PMID: 34089587